The page describes central and obstructive sleep apnea as distinct disorders with different triggers and health effects. Obstructive sleep apnea involves an airway blockage, while central sleep apnea occurs when the brain fails to signal breathing.
The page describes obstructive sleep apnea as a prevalent disorder affecting millions worldwide, with pauses or shallow breaths during sleep that disrupt sleep patterns and reduce blood oxygen levels.
The page describes an FDA-cleared oral appliance alternative to CPAP for moderate to severe OSA. It states that most patients experience significant improvement in obstructive sleep apnea symptoms and many experience complete resolution.
The privacy notice, last updated September 30, 2020, applies to Vivos Therapeutics, Inc., Vivos.com, and websites operated by Vivos Therapeutics. Using these sites constitutes consent to the data practices described in the notice.